Bioinformatics;Immunology;Virology;Computer-aided drug design;Drug binding;Infectious disease;Viral protein;Viruses;SARS-CoV-2;Receptor binding domain;Virtual screening;Lead compounds;Anti-Viral drugs;COVID-19